Gout Disease Treatment Market: Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021

Request Brochure Request Discount

Report Code: ZMR-233 | Report Format : | Status : Upcoming |

Abstract

Gout is a disease that is caused by frequent attacks of acute inflammatory arthritis. The symptoms of this disease include red and swollen joint, itching skin, limited movement of the affected part, and others. Also, the uric acid crystallizes and the crystals deposit in joints, tendons and adjacent tissues which cause a gout attack. The human body produces uric acid when it is broken down into purines. Purines are substances that are already present naturally in the body in the form of food consumed by the humans. It is caused due to a combination of genetic factor and diet. Usually, the person consuming large amounts of meat and beer faces this disease.

The global gout disease treatment market is segmented on the basis of disease therapeutics and the conditional stage. The conditional stage segment is sub-segmented as acute gout and chronic gout. The therapeutic segment is further sub-segmented as urate-lowering therapies and inflammatory. The global market is segmented on the basis of the product as colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. NSAIDs are widely used for the treatment of gout disease, while corticosteroids and colchicines are the alternative treatment for the patients who are unable to tolerate the effects of NSAIDs.

The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and introduction of niche drugs are other factors boosting the growth of the global gout disease treatment market. Progressive collaboration between major companies and quick product launches are some key factors impacting the growth of the market in a positive way. On the other hand, strict regulations and patent expiry of various drugs may act key restraining factors for the global gout disease treatment market.

North America and Europe dominate the global gout disease treatment market mainly owing to the enhanced pharmaceutical research in this area. North America is the leading player in the gout therapeutics market due to increased geriatric population with modernized routine disorders. In addition, the U.S holds the biggest market for gout disease treatment, followed by Canada in North America. Furthermore, Asia is anticipated to witness high growth in the near future owing to increasing awareness among people about the disease. Japan, China, and India are expected to grow rapidly in the gout disease treatment market in Asia.

Some of the major players dominating the global gout disease treatment market are Novartis AG, AstraZeneca PLC, Polaris Group, Teijin Pharma Limited, BioCryst Pharmaceuticals, Inc., Nippon Chemiphar Co., Ltd., and JW Pharmaceutical Corporation. Other key players influencing the global market are Addex Therapeutics, Takeda Pharmaceutical Company, LG Life Sciences Ltd., Pfizer, and Merck.

Gout Disease Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany 
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Real World Evidence Solutions Market by Component (Data Sets and Services), by Therapeutic Area (Oncology, Cardiovascular Disease, Neurology, Immunology, and Others), and by End-Users (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2026

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3365 | Report Format:

The report covers forecast and analysis for the real world evidence solutions market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the real wor...Read More

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, and Octreotide) and by Application (Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3360 | Report Format:

The report covers forecast and analysis for the oral proteins and peptides market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the oral prot...Read More

Medical Display Market by Technology (OLED, CCFL-Backlit LCD, and LED-Backlit LCD), by Display Color (Monochrome Displays and Color Displays), and by Resolution (Up to 2mp Resolution, 2.1–4mp Resolution, 4.1–8mp Resolution, and above 8mp Resolution), by Panel Size (Under-22.9-Inch, 23.0–26.9-Inch, 27.0–41.9-Inch, and Above-42-Inch), and by Application (Surgical, Diagnostic, Dentistry, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3358 | Report Format:

The report covers forecast and analysis for the medical display market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the medical display...Read More

Facial Rejuvenation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3351 | Report Format:

Global Facial Rejuvenation Market: Overview Facial rejuvenation is a mixture of various medical and cosmetic procedures which are used in order to restore a youthful appearance to the human face. It can be achieved through non-invasive or minimally invasive surgical or non-surgical procedures. T...Read More

Scleroderma Diagnostics and Therapeutics Market by Drug Class (Immunosuppressive Agents, Corticosteroids, Endothelin Receptor Agonists, Calcium Channel Blockers, Chelating Agents, PDE-5 Inhibitors, H2 Blockers, Prostacyclin Analogues, ACE Inhibitors, and Proton Pump Inhibitors), by Indication (Systemic and Localized), and by Diagnostic Test Type (Imaging Techniques, Skin Biopsy, Electrocardiogram and Echocardiogram, Pulmonary Function Tests, and Blood Test): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3321 | Report Format:

The report covers forecast and analysis for the scleroderma diagnostics and therapeutics market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the scl...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.